News

PHEXCOM

Solution BY Communication

Call：+86 021-55807300

Position：Home > News >

Merck, plagued by limited supply of bladder cancer drug, will build new facility to triple production

During its years as sole producer of a difficult-to-make cancer med in high demand, Merck & Co.'s limited capacity has hamstrung its efforts to get the drug into patients' hands.Now, Merckis putt
2020/10/10
ESMO: Bristol Myers' Opdivo racks up GI cancer data for 2 potentially practice-changing FDA nods

Gastrointestinal cancers are stubborn, as plenty of oncology drugmakers know. But Bristol Myers Squibb’s immunotherapy Opdivo has broken through with a couple of potentially practice-changing trials
2020/9/25
AstraZeneca, Samsung reach $331M biologics manufacturing deal amid Korean CMO's expansion push

Unlike some other manufacturers, Samsung Biologics has enjoyed a revenue boost from the novel coronavirus pandemic, and it's accelerating its expansion plans to match. With a $2 billion "super plant"
2020/9/25
Former Biogen CFO Capello scores $2.6M payment plus full severance benefits on his way out

After bringing ina new CFO this summer—and as it navigates a turbulent stretch—Biogenis givingformerchief finance officer Jeff Capello a multimillion-dollar cash paymentplus other severance benefits.
2020/9/24
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week

After thelate Rep. Elijah Cummingslaunched a drug pricing probe of some of the industry's largest players last January, six pharmaceutical execs are set to head to Washington next week forhearings at
2020/9/24
Humanigen, Thermo Fisher strike deal to scale up manufacturing of monoclonal antibody for COVID-19

In the earliest days of the COVID-19 pandemic, a suite of drugmakers looked to monoclonal antibodies to fight the immune system overreaction seen in severe patients. Months later, most of those candi
2020/9/23
Sun Pharma the latest to recall metformin after carcinogen tests come up positive

Once cleared by the FDA of a probable carcinogen, generic diabetes med metformin has now been the target of a growingnumber of recalls. This week, a seventh drugmaker has joined the metformin recall
2020/9/23
Fujifilm's flu drug Avigan improves COVID-19 recovery time, setting up filing in Japan

Six months after the World Health Organization declared COVID-19 a global pandemic, the list of drugs with proven efficacy againstthe virus remains short. On Wednesday, Fujifilm added itsflu drug Avi
2020/9/22
ICER rubber-stamps Vertex's $311K CF drug Trikafta but blasts 'monopoly' pricing

No one disputes the therapeutic value of Vertex Pharmaceuticals’ triplet drug Trikafta for cystic fibrosis—not even the cost watchdogs at the Institute for Clinical and Economic Review (ICER). But IC
2020/9/22
With U.S. elections nearing, European pharma giants brace for potential pricing action: analysts

With U.S. presidential and congressional campaignsin full swing, it’s not just Americans anxiously awaitingthe results of the upcoming elections. The races couldaffect European pharma companies in a
2020/9/21

Excipients